These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcome. Krauth MT; Eder C; Alpermann T; Bacher U; Nadarajah N; Kern W; Haferlach C; Haferlach T; Schnittger S Leukemia; 2014 Jul; 28(7):1449-58. PubMed ID: 24402164 [TBL] [Abstract][Full Text] [Related]
6. The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia. Qin YZ; Wang Y; Xu LP; Zhang XH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Chen Y; Mo XD; Zhao XS; Chang YJ; Liu KY; Huang XJ J Hematol Oncol; 2017 Feb; 10(1):44. PubMed ID: 28166825 [TBL] [Abstract][Full Text] [Related]
7. Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1. Liu H; Wang SA; Schlette EJ; Xu J; Jorgensen JL; Cameron Yin C; Li S; Jeffrey Medeiros L; Tang G Ann Hematol; 2018 Oct; 97(10):1775-1783. PubMed ID: 29872884 [TBL] [Abstract][Full Text] [Related]
8. [Frequency and clinical features of ASXL2 gene mutation in acute myeloid leukemia patients with AML1- ETO fusion gene positive]. Zhao JX; Chen XH; Li JL; Pan J; Tan YH; Xu ZF; Ren FG; Zhang YF; Xu J; Li MQ; Li J; Zhang N; Chang JM; Wang XJ; Wang HW Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):676-81. PubMed ID: 27587249 [TBL] [Abstract][Full Text] [Related]
9. Novel Four-Way t(8;14;15;21)(q22;q22;q15;q22.1) Translocation Variant in Acute Myeloid Leukemia with Tsuge N; Ogasawara F; Kondo T; Yoshida S; Kojima K Turk J Haematol; 2024 May; 41(2):128-129. PubMed ID: 38488305 [No Abstract] [Full Text] [Related]
10. Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation. Qin YZ; Wang Y; Zhu HH; Gale RP; Zhang MJ; Jiang Q; Jiang H; Xu LP; Chen H; Zhang XH; Liu YR; Lai YY; Jiang B; Liu KY; Huang XJ Chin J Cancer; 2016 May; 35():46. PubMed ID: 27197573 [TBL] [Abstract][Full Text] [Related]
11. Transformation into acute myeloid leukemia with t(8;21)(q22;q22.1); RUNX1::RUNX1T1 from JAK2-mutated essential thrombocythemia: a case report. Asou C; Sakamoto T; Suzuki K; Okuda I; Osaki A; Abe R; Ito Y; Kakegawa E; Miyakawa Y; Terui Y; Nakamura Y J Med Case Rep; 2024 Aug; 18(1):372. PubMed ID: 39154170 [TBL] [Abstract][Full Text] [Related]
12. Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML). Agrawal M; Schwarz P; Giaimo BD; Bedzhov I; Corbacioglu A; Weber D; Gaidzik VI; Jahn N; Rücker FG; Schroeder T; Kindler T; Wattad M; Götze K; Lübbert M; Salwender H; Ringhoffer M; Lange E; Koller E; Thol F; Heuser M; Ganser A; Bullinger L; Paschka P; Döhner H; Geiger H; Borggrefe T; Döhner K; Oswald F Leukemia; 2020 Feb; 34(2):630-634. PubMed ID: 31462736 [No Abstract] [Full Text] [Related]
13. Effects of c-KIT mutations on expression of the RUNX1/RUNX1T1 fusion transcript in t(8;21)-positive acute myeloid leukemia patients. Park SH; Chi HS; Cho YU; Jang S; Park CJ Leuk Res; 2013 Jul; 37(7):784-9. PubMed ID: 23528260 [TBL] [Abstract][Full Text] [Related]
14. Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA. Duployez N; Nibourel O; Marceau-Renaut A; Willekens C; Helevaut N; Caillault A; Villenet C; Celli-Lebras K; Boissel N; Jourdan E; Dombret H; Figeac M; Preudhomme C; Renneville A Am J Hematol; 2014 Jun; 89(6):610-5. PubMed ID: 24616160 [TBL] [Abstract][Full Text] [Related]
15. t(2;2;21;8)(p21;q37;q22;q22), a novel four-way complex translocation involving variant t(8;21) in case of acute myeloid leukemia : A case report and literature review. Han B; Jing Y; Bi X; Lin Y; Li H; Li H; Ru K; Yang S Cancer Genet; 2024 Jun; 284-285():1-4. PubMed ID: 38460349 [TBL] [Abstract][Full Text] [Related]
16. Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial. Yin JA; O'Brien MA; Hills RK; Daly SB; Wheatley K; Burnett AK Blood; 2012 Oct; 120(14):2826-35. PubMed ID: 22875911 [TBL] [Abstract][Full Text] [Related]
17. Rearrangement of VPS13B, a causative gene of Cohen syndrome, in a case of RUNX1-RUNX1T1 leukemia with t(8;12;21). Abe A; Yamamoto Y; Katsumi A; Okamoto A; Tokuda M; Inaguma Y; Yamamoto K; Yanada M; Kanie T; Tomita A; Akatsuka Y; Okamoto M; Kameyama T; Mayeda A; Emi N Int J Hematol; 2018 Aug; 108(2):208-212. PubMed ID: 29264741 [TBL] [Abstract][Full Text] [Related]
18. Salmon-coloured granules in residual acute myeloid leukaemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1. Chen D; Chen W Br J Haematol; 2021 May; 193(4):691. PubMed ID: 33386742 [No Abstract] [Full Text] [Related]
20. Prognostic Role of Postinduction Minimal Residual Disease and Myeloid Sarcoma Type Extramedullary Involvement in Pediatric RUNX1-RUNX1T1 (+) Acute Myeloid Leukemia. Lee JW; Kim S; Jang PS; Chung NG; Cho B; Im SA; Kim M J Pediatr Hematol Oncol; 2020 Apr; 42(3):e132-e139. PubMed ID: 31688618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]